Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202061 | 12620206 | 1 | I | 20160725 | 20160803 | 20160803 | EXP | AU-BAUSCH-BL-2016-018017 | BAUSCH AND LOMB | MCFADDEN M, GORDON A, LEONG G, WARD D, SCOTT J. PANCREATITIS ASSOCIATED WITH METFORMIN USED FOR MANAGEMENT OF CLOZAPINE-RELATED WEIGHT GAIN. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2016;1-1. | 17.00 | YR | M | Y | 0.00000 | 20160803 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202061 | 12620206 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 21748 | 500 | MG | ||||||||
| 126202061 | 12620206 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 21748 | 500 | MG | BID | |||||||
| 126202061 | 12620206 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 21748 | 1500 | MG | BID | |||||||
| 126202061 | 12620206 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 21748 | 500 | MG | BID | |||||||
| 126202061 | 12620206 | 5 | C | CLOZAPINE. | CLOZAPINE | 1 | 0 | ||||||||||||
| 126202061 | 12620206 | 6 | C | CLOZAPINE. | CLOZAPINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126202061 | 12620206 | 1 | Weight control |
| 126202061 | 12620206 | 5 | Schizophrenia |
| 126202061 | 12620206 | 6 | Intellectual disability |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126202061 | 12620206 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126202061 | 12620206 | Neutrophilia | |
| 126202061 | 12620206 | Off label use | |
| 126202061 | 12620206 | Overdose | |
| 126202061 | 12620206 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |